Glomerulonephritis in patients with previous coronavirus infection. Risks and consequences

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Glomerulonephritis (GN) is a group of autoimmune inflammatory diseases that occur in the glomeruli of the kidneys and lead to a decrease in nephron function. Currently, the exact cause of GN is unclear, but there are several different putative mechanisms, among which the leading role is given to infectious agents and environmental factors. It is known that group B β-hemolytic streptococcus, human immunodeficiency virus, hepatitis B virus and hepatitis C virus, as well as parvovirus, have a tendency to develop kidney diseases. One of the potential agents may be the SARS-CoV-2 coronavirus, which has a fairly well-studied mechanism of binding to kidney structures and causing acute kidney injury, the central link in the pathogenesis of which is GN. In this article, the pathophysiological mechanisms of GN occurrence, possible ways of GN development associated with coronavirus infection are discussed, and possible medium- and long-term consequences for the corresponding patients are described. This article is written in the format of a literature review.

全文:

受限制的访问

作者简介

Ivan Polovikov

N.F.Sklifosovsky Institute of Clinical Medicine, Sechenov University

编辑信件的主要联系方式.
Email: polovikov_i_p@staff.sechenov.ru
ORCID iD: 0000-0002-3129-9397

Student

俄罗斯联邦, Moscow

Valeria Zakharova

Sechenov University

Email: zakharova_v_l@staff.sechenov.ru
ORCID iD: 0000-0001-5407-6906

Cand.Sci.(Med.), Associate Professor at the Department of Medical and Social Expertise, Emergency and Outpatient Therapy

俄罗斯联邦, Moscow

Zhanna Sizova

Sechenov University

Email: sizova_zh_m@staff.sechenov.ru
ORCID iD: 0000-0002-1242-7074

Dr.Sci.(Med.), Professor, Head of the Department of Medical and Social Expertise, Emergency and Outpatient Therapy, Institute of Postgraduate Education

俄罗斯联邦, Moscow

Natalia Lapidus

Sechenov University

Email: lapidus_n_i@staff.sechenov.ru
ORCID iD: 0000-0002-2222-836X

Cand.Sci.(Med.), Associate Professor at the Department of Medical and Social Expertise, Emergency and Outpatient Therapy

俄罗斯联邦, Moscow

Denis Shoikhet

Sechenov University

Email: shoykhet_d_a@staff.sechenov.ru
ORCID iD: 0009-0005-0420-446X

Teaching Assistant, Department of Microbiology, Virology and Immunology, Medical and Social Expertise

俄罗斯联邦, Moscow

Nadezhda Lenkova

Sechenov University

Email: lenkova_n_i@staff.sechenov.ru

Associate Professor at the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases

俄罗斯联邦, Moscow

参考

  1. Keskinyan V.S., Lattanza B., Reid-Adam J. Glomerulonephritis. Pediatr. Rev. 2023;44(9):498–512. doi: 10.1542/pir.2021-005259. [PMID: 37653138].
  2. Oda T., Yoshizawa N. Factors Affecting the Progression of Infection-Related Glomerulonephritis to Chronic Kidney Disease. Int. J. Mol. Sci. 2021;22(2):905. doi: 10.3390/ijms22020905. [PMID: 33477598; PMCID: PMC7831296].
  3. Rawla P., Padala S.A., Ludhwani D. Poststreptococcal Glomerulonephritis. 2022 Oct 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls. Publishing; 2024 Jan. [PMID: 30855843].
  4. Brant Pinheiro S.V., de Freitas V.B., de Castro G.V., et al. Acute Post-Streptococcal Glomerulonephritis in Children: A Comprehensive Review. Curr. Med. Chem. 2022;29(34):5543–59. doi: 10.2174/ 0929867329666220613103316. [PMID: 35702785].
  5. Rivera F.B., Ansay M.F.M., Golbin J.M., et al. HIV-Associated Nephropathy in 2022. Glomerular Dis. 2022;3(1):1–11. doi: 10.1159/000526868. [PMID: 36816427, PMCID: PMC9936764].
  6. Zhang L., Carson J.M., Lucia M.S. Fibrillary glomerulonephritis in an HIV patient without concurrent hepatitis C infection: Case report and review of the literature. Clin. Nephrol. 2018;89(5):381–86. doi: 10.5414/CN109215. [PMID: 29578397].
  7. Ozkok A., Yildiz A. Hepatitis C virus associated glomerulopathies. World J. Gastroenterol. 2014;20(24):7544–54. doi: 10.3748/ wjg.v20.i24.7544. [PMID: 24976695, PMCID: PMC4069286].
  8. Hardenberg J.B., Luft F.C. Covid-19, ACE2 and the kidney. Acta Physiol. (Oxf). 2020;230(1):e13539. doi: 10.1111/apha.13539. [Epub 2020 Aug 2, PMID: 32662161, PMCID: PMC7404369].
  9. Klomjit N., Zand L, Cornell L.D., Alexander M.P. COVID-19 and Glomerular Diseases. Kidney Int. Rep. 2023;8(6):1137–50. doi: 10.1016/j.ekir.2023.03.016. [Epub 2023 Mar 27, PMID: 37274308, PMCID: PMC10041821].
  10. Sabaghian T., Kharazmi A.B., Ansari A., et al. COVID-19 and Acute Kidney Injury: A Systematic Review. Front. Med. (Lausanne). 2022;9: 705908. doi: 10.3389/fmed.2022.705908. [PMID: 35445048, PMCID: PMC9014846].
  11. Yang X., Tian S., Guo H. Acute kidney injury and renal replacement therapy in COVID-19 patients: a systematic review and meta-analysis. Int. Immunopharmacol. 2021;90. doi: 10.1016/j.intimp.2020.107159.
  12. Vivekanand N., Singh R.K.N., Kumari N., et al. A Novel Association Between Coronavirus Disease 2019 and Normocomplementemic Rapidly Progressive Glomerulonephritis-Crescentic Immunoglobulin A Nephropathy: A Report of Two Pediatric Cases. Cureus. 2022;14(2):e22077. doi: 10.7759/cureus.22077. [PMID: 35308719, PMCID: PMC8920789].
  13. Román J.L., Vergara A., Agraz I., et al. Focal and segmental glomerulosclerosis associated with COVID-19 infection. Nefrologia (Engl Ed). 2021;41(6):706–8. doi: 10.1016/j.nefroe.2021.12.008. [Epub 2022 Jan 20, PMID: 36165163, PMCID: PMC8769713].
  14. de Francisco M.Á., Fresnedo F.G. Long COVID-19 renal disease: A present medical need for nephrology. Nefrologia (Engl Ed). 2023;43(1):1–5. doi: 10.1016/j.nefroe.2023.03.011. [Epub 2023 Mar 30, PMID: 37031074, PMCID: PMC10060193].
  15. Gauckler P., Kesenheimer J.S., Geetha D., et al. COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases. Front. Immunol. 2023;14:1228457. doi: 10.3389/fimmu.2023.1228457. [PMID: 37767096, PMCID: PMC10520971].
  16. Roy Chaudhary A., Sengupta M., Basu K., et al. Pos-017 covid associated glomerulonephritis- an alarm for atypical infection related glomerulonephritis. Kidney Int. Rep. 2022;7(9):S469–70. doi: 10.1016/j.ekir.2022.07.032. [Epub 2022 Sep 15, PMCID: PMC9475085].
  17. Ota Y., Kuroki R., Iwata M., et al. Association between COVID-19 vaccination and relapse of glomerulonephritis. Clin. Exp. Nephrol. 2023;27(3):236–42. doi: 10.1007/s10157-022-02299-6. [Epub 2022 Nov 23, PMID: 36422760, PMCID: PMC9686234].
  18. Diebold M., Locher E., Boide P., et al. Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased. Kidney Int. 2022;102(6):1409–19. doi: 10.1016/j.kint.2022.08.021.

补充文件

附件文件
动作
1. JATS XML
下载